Advertisement
Research Article Free access | 10.1172/JCI110908
Department of Medicine, University of Colorado Health Sciences Center, Division of Endocrinology, Denver, Colorado 80262
Denver Veterans Administration Hospital, Denver, Colorado 80262
Find articles by Fink, R. in: JCI | PubMed | Google Scholar
Department of Medicine, University of Colorado Health Sciences Center, Division of Endocrinology, Denver, Colorado 80262
Denver Veterans Administration Hospital, Denver, Colorado 80262
Find articles by Kolterman, O. in: JCI | PubMed | Google Scholar
Department of Medicine, University of Colorado Health Sciences Center, Division of Endocrinology, Denver, Colorado 80262
Denver Veterans Administration Hospital, Denver, Colorado 80262
Find articles by Griffin, J. in: JCI | PubMed | Google Scholar
Department of Medicine, University of Colorado Health Sciences Center, Division of Endocrinology, Denver, Colorado 80262
Denver Veterans Administration Hospital, Denver, Colorado 80262
Find articles by Olefsky, J. in: JCI | PubMed | Google Scholar
Published June 1, 1983 - More info
We have studied 17 elderly and 27 non-elderly, nonobese subjects (mean age 69±1 and 37±2 yr, respectively) to assess the mechanisms responsible for the abnormal carbohydrate tolerance associated with aging. Serum glucose and insulin levels were significantly elevated in the elderly subjects compared with the nonelderly subjects during a 75-g oral glucose tolerance test, suggesting an insulin resistant state. Peripheral insulin sensitivity was assessed in both groups using the euglycemic glucose clamp technique during an insulin infusion rate of 40 mU/m2 per min. Similar steady-state serum insulin levels led to a peripheral glucose disposal rate of 151±17 mg/m2 per min in the elderly compared with a value of 247±12 mg/m2 per min in the nonelderly, thus documenting the presence of insulin resistance in the elderly subjects. Insulin binding to isolated adipocytes and monocytes was similar in the elderly and nonelderly groups (2.34±0.33 vs. 2.62±0.24% and 5.04±1.10 vs. 5.12±1.07%), respectively. Thus, insulin resistance in the presence of normal insulin binding suggests the presence of a postreceptor defect in insulin action. This was confirmed by performing additional euglycemic clamp studies using infusion rates of 15 and 1,200 mU/m2 per min to assess the contours of the dose-response relationship. These studies revealed a 39 and 25% decrease in the glucose disposal rate in the elderly subjects, respectively. The results confirm the presence of a postreceptor defect as well as a rightward shift in the dose-response curve. Insulin's ability to suppress hepatic glucose output was less in the elderly subjects during the 15 mU/m2 per min insulin infusion (77±5 vs. 89±4% suppression), but hepatic glucose output was fully and equally suppressed in both groups during the 40 and 1,200 mU/m2 per min infusion. Finally, a significant inverse relationship was observed between the degree of glucose intolerance in the individual elderly subjects, as reflected by the 2-h serum glucose level during the oral glucose tolerance test, and the degree of peripheral insulin resistance as assessed by the glucose disposal rate during the 40 mU/m2 per min insulin infusion (r = 0.59, P < 0.01).
We conclude that carbohydrate intolerance develops as part of the aging process. This carbohydrate intolerance appears to be the consequence of peripheral insulin resistance caused by a postreceptor defect in target tissue insulin action, which causes both a decrease in the maximal rate of peripheral glucose disposal and a rightward shift in the insulin action dose-response curve. In elderly subjects, the severity of the abnormality in carbohydrate tolerance is directly correlated to the degree of peripheral insulin resistance.